{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:43:55Z","timestamp":1771659835851,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/jhh.2015.121","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T11:23:22Z","timestamp":1453375402000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study"],"prefix":"10.1038","volume":"30","author":[{"given":"A N","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A I","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Claas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Boerwinkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C E","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Eckfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H K","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D K","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Irvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"1","key":"BFjhh2015121_CR1","first-page":"e6","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association. Circulation 2013; 127 (1): e6\u2013e245.","journal-title":"Circulation"},{"issue":"5","key":"BFjhh2015121_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","volume":"56","author":"JM Flack","year":"2010","unstructured":"Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr. et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010; 56 (5): 780\u2013800.","journal-title":"Hypertension"},{"issue":"13","key":"BFjhh2015121_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","volume":"118","author":"JA Johnson","year":"2008","unstructured":"Johnson JA . Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 2008; 118 (13): 1383\u20131393.","journal-title":"Circulation"},{"issue":"5","key":"BFjhh2015121_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.tpj.6500113","volume":"2","author":"DK Arnett","year":"2002","unstructured":"Arnett DK, Boerwinkle E, Davis BR, Eckfeldt J, Ford CE, Black H . Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study. Pharmacogenomics J 2002; 2 (5): 309\u2013317.","journal-title":"Pharmacogenomics J"},{"issue":"2 Pt 2","key":"BFjhh2015121_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.37.2.739","volume":"37","author":"ST Turner","year":"2001","unstructured":"Turner ST, Schwartz GL, Chapman AB, Boerwinkle E . C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37 (2 Pt 2): 739\u2013743.","journal-title":"Hypertension"},{"issue":"5","key":"BFjhh2015121_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1046\/j.1523-1755.2002.00624.x","volume":"62","author":"GL Schwartz","year":"2002","unstructured":"Schwartz GL, Turner ST, Chapman AB, Boerwinkle E . Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 2002; 62 (5): 1718\u20131723.","journal-title":"Kidney Int"},{"issue":"1","key":"BFjhh2015121_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.tpj.6500215","volume":"4","author":"L Frazier","year":"2004","unstructured":"Frazier L, Turner ST, Schwartz GL, Chapman AB, Boerwinkle E . Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic. Pharmacogenomics J 2004; 4 (1): 17\u201323.","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"BFjhh2015121_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/01.HYP.0000186240.81996.57","volume":"46","author":"ST Turner","year":"2005","unstructured":"Turner ST, Schwartz GL, Chapman AB, Boerwinkle E . WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 2005; 46 (4): 758\u2013765.","journal-title":"Hypertension"},{"issue":"4","key":"BFjhh2015121_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/HYPERTENSIONAHA.112.198721","volume":"60","author":"AG Vandell","year":"2012","unstructured":"Vandell AG, Lobmeyer MT, Gawronski BE, Langaee TY, Gong Y, Gums JG et al. G protein receptor kinase 4 polymorphisms: beta-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012; 60 (4): 957\u2013964.","journal-title":"Hypertension"},{"issue":"8","key":"BFjhh2015121_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/FPC.0b013e32833b5958","volume":"20","author":"JD Duarte","year":"2010","unstructured":"Duarte JD, Lobmeyer MT, Wang Z, Chapman AB, Gums JG, Langaee TY et al. Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide. Pharmacogenet Genomics 2010; 20 (8): 516\u2013519.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"BFjhh2015121_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FPC.0b013e328341e911","volume":"21","author":"MT Lobmeyer","year":"2011","unstructured":"Lobmeyer MT, Wang L, Zineh I, Turner ST, Gums JG, Chapman AB et al. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients. Pharmacogenet Genomics 2011; 21 (1): 42\u201349.","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"BFjhh2015121_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.107.104273","volume":"52","author":"ST Turner","year":"2008","unstructured":"Turner ST, Bailey KR, Fridley BL, Chapman AB, Schwartz GL, Chai HS et al. Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension 2008; 52 (2): 359\u2013365.","journal-title":"Hypertension"},{"issue":"2","key":"BFjhh2015121_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.111.00436","volume":"62","author":"ST Turner","year":"2013","unstructured":"Turner ST, Boerwinkle E, O'Connell JR, Bailey KR, Gong Y, Chapman AB et al. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide. Hypertension 2013; 62 (2): 391\u2013397.","journal-title":"Hypertension"},{"issue":"3","key":"BFjhh2015121_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/tpj.2012.4","volume":"13","author":"JD Duarte","year":"2013","unstructured":"Duarte JD, Turner ST, Tran B, Chapman AB, Bailey KR, Gong Y et al. Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression. Pharmacogenomics J 2013; 13 (3): 257\u2013263.","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"BFjhh2015121_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/HJH.0b013e32835e2a71","volume":"31","author":"CW McDonough","year":"2013","unstructured":"McDonough CW, Burbage SE, Duarte JD, Gong Y, Langaee TY, Turner ST et al. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. J Hypertens 2013; 31 (4): 698\u2013704.","journal-title":"J Hypertens"},{"issue":"6","key":"BFjhh2015121_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCGENETICS.112.964080","volume":"5","author":"Y Gong","year":"2012","unstructured":"Gong Y, McDonough CW, Wang Z, Hou W, Cooper-DeHoff RM, Langaee TY et al. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet 2012; 5 (6): 686\u2013691.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"BFjhh2015121_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/HYP.0b013e31825b30f8","volume":"59","author":"ST Turner","year":"2012","unstructured":"Turner ST, Bailey KR, Schwartz GL, Chapman AB, Chai HS, Boerwinkle E . Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. Hypertension 2012; 59 (6): 1204\u20131211.","journal-title":"Hypertension"},{"issue":"4 Pt 1","key":"BFjhh2015121_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","volume":"9","author":"BR Davis","year":"1996","unstructured":"Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr., Cushman WC et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Research Group. Am J Hypertens 1996; 9 (4 Pt 1): 342\u2013360.","journal-title":"Am J Hypertens"},{"issue":"10","key":"BFjhh2015121_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1751-7176.2008.00015.x","volume":"10","author":"WC Cushman","year":"2008","unstructured":"Cushman WC, Ford CE, Einhorn PT, Wright JT Jr., Preston RA, Davis BR et al. Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 2008; 10 (10): 751\u2013760.","journal-title":"J Clin Hypertens"},{"issue":"10","key":"BFjhh2015121_CR20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1097\/HJH.0b013e32833c7a4d","volume":"28","author":"MR Irvin","year":"2010","unstructured":"Irvin MR, Lynch AI, Kabagambe EK, Tiwari HK, Barzilay JI, Eckfeldt JH et al. Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study. J Hypertens 2010; 28 (10): 2076\u20132083.","journal-title":"J Hypertens"},{"issue":"10","key":"BFjhh2015121_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1101\/gr.9.10.936","volume":"9","author":"S Cheng","year":"1999","unstructured":"Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999; 9 (10): 936\u2013949.","journal-title":"Genome Res"},{"issue":"3","key":"BFjhh2015121_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ajh.2008.341","volume":"22","author":"V Bhatnagar","year":"2009","unstructured":"Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM et al. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens 2009; 22 (3): 332\u2013338.","journal-title":"Am J Hypertens"},{"key":"BFjhh2015121_CR23","doi-asserted-by":"crossref","unstructured":"Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension. Br Med J 1986; 293 (6553): 988\u2013992.","DOI":"10.1136\/bmj.293.6553.988"},{"issue":"4","key":"BFjhh2015121_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/1470320313506481","volume":"15","author":"H Yu","year":"2014","unstructured":"Yu H, Lin S, Zhong J, He M, Jin L, Zhang Y et al. A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors. J Renin Angiotensin Aldosterone Syst 2014; 15 (4): 540\u2013546.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"11","key":"BFjhh2015121_CR25","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.amjhyper.2005.05.031","volume":"18","author":"DA Patel","year":"2005","unstructured":"Patel DA, Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS et al. G-6A polymorphism of the angiotensinogen gene and its association with left ventricular mass in asymptomatic young adults from a biethnic community: the Bogalusa Heart Study. Am J Hypertens 2005; 18 (11): 1437\u20131441.","journal-title":"Am J Hypertens"},{"issue":"8 Suppl B","key":"BFjhh2015121_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","volume":"13","author":"SA Atlas","year":"2007","unstructured":"Atlas SA . The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007; 13 (8 Suppl B): 9\u201320.","journal-title":"J Manag Care Pharm"},{"issue":"6","key":"BFjhh2015121_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1586\/erc.10.27","volume":"8","author":"JD Duarte","year":"2010","unstructured":"Duarte JD, Cooper-DeHoff RM . Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther 2010; 8 (6): 793\u2013802.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"BFjhh2015121_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/NEJM199801083380202","volume":"338","author":"L Lacoviello","year":"1998","unstructured":"Lacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Amore C, Arboretti R et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338 (2): 79\u201385.","journal-title":"N Engl J Med"},{"issue":"5","key":"BFjhh2015121_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1160\/TH08-11-0761","volume":"101","author":"T Fujimaki","year":"2009","unstructured":"Fujimaki T, Kato K, Yoshida T, Oguri M, Watanabe S, Metoki N et al. Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease. Thromb Haemost 2009; 101 (5): 963\u2013968.","journal-title":"Thromb Haemost"},{"issue":"3","key":"BFjhh2015121_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12041-009-0042-x","volume":"88","author":"J Shanker","year":"2009","unstructured":"Shanker J, Perumal G, Maitra A, Rao VS, Natesha BK, John S et al. Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease. J Genet 2009; 88 (3): 291\u2013297.","journal-title":"J Genet"},{"issue":"2","key":"BFjhh2015121_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1538-7836.2010.04149.x","volume":"9","author":"NA Zakai","year":"2011","unstructured":"Zakai NA, Lange L, Longstreth WT Jr., O'Meara ES, Kelley JL, Fornage M et al. Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study. J Thromb Haemost 2011; 9 (2): 267\u2013274.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"BFjhh2015121_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/STROKEAHA.110.593798","volume":"42","author":"R Sherva","year":"2011","unstructured":"Sherva R, Ford CE, Eckfeldt JH, Davis BR, Boerwinkle E, Arnett DK . Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study. Stroke 2011; 42 (2): 330\u2013335.","journal-title":"Stroke"},{"issue":"3","key":"BFjhh2015121_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cardiores.2005.07.015","volume":"69","author":"S Ye","year":"2006","unstructured":"Ye S . Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006; 69 (3): 636\u2013645.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"BFjhh2015121_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.amjhyper.2006.04.013","volume":"19","author":"R Fogari","year":"2006","unstructured":"Fogari R, Zoppi A . Antihypertensive drugs and fibrinolytic function. Am J Hypertens 2006; 19 (12): 1293\u20131299.","journal-title":"Am J Hypertens"},{"key":"BFjhh2015121_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","volume":"936","author":"HR Lijnen","year":"2001","unstructured":"Lijnen HR . Elements of the fibrinolytic system. Ann N Y Acad Sci 2001; 936: 226\u2013236.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh2015121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh2015121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh2015121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T16:41:49Z","timestamp":1647535309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh2015121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFjhh2015121"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2015.121","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]},"assertion":[{"value":"29 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}